UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
OMB  APPROVAL
 
OMB Number:  3235-0060
Expires:  June 30, 2009
Estimated average burden hours per response5.00
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  




Date of Report (Date of earliest event reported)                                        August 10, 2009                      


SOMANETICS CORPORATION
(Exact name of registrant as specified in its charter)

Michigan
  
0-19095
  
38-2394784
(State or other jurisdiction
  
(Commission
  
(IRS Employer
of incorporation)
  
File Number)
  
Identification No.)


 
1653 East Maple Road, Troy, Michigan
48083-4208
  (Address of principal executive offices)
 (Zip Code)

Registrant’s telephone number, including area code                               (248) 689-3050                       

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communication pursuant to Rule 425 under the Securities Act.
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

 
 
 


 
Item 7.01.   Regulation FD Disclosure

On August 10, 2009, Somanetics Corporation announced that it has filed a patent infringement action again CAS Medical Systems, Inc. in the United States District Court for the Eastern District of Michigan.  A copy of the press release is furnished with this report following the signature page and is incorporated in this Item 7.01 by reference.  The information in this report and the attached press release shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly stated by specific reference in such filing.


Item 9.01.   Financial Statements and Exhibits

Exhibits
Description
      
99.1
News release dated August 10, 2009
 
 
 
 
 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated:  August 10, 2009
           SOMANETICS CORPORATION                
 
(Registrant)
        
 
By:
         /s/ Mary Ann Victor          
   
Mary Ann Victor
     

   
Its:
     Vice President and Chief
     Administrative Officer and Secretary
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT INDEX

Exhibits
Description
 
99.1
News release dated August 10, 2009